Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.65 USD | -1.49% | -3.98% | -8.30% |
02-12 | Acasti Pharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 | CI |
02-07 | Craig-Hallum Initiates Acasti Pharma With Buy Rating, $6 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.30% | 24.91M | |
+38.69% | 728B | |
+33.58% | 603B | |
-4.49% | 360B | |
+20.24% | 332B | |
+2.12% | 279B | |
+15.93% | 244B | |
+7.56% | 207B | |
-5.56% | 205B | |
-0.35% | 163B |
- Stock Market
- Equities
- ACST Stock
- News Acasti Pharma Inc.
- Acasti Pharma Appoints Prashant Kohli as CEO; to Proceed with Phase 3 Clinical Safety Study for GTX-104 Post FDA Feedback